Defective interfering viruses and their potential as antiviral agents
- PMID: 20041441
- DOI: 10.1002/rmv.641
Defective interfering viruses and their potential as antiviral agents
Abstract
Defective interfering (DI) virus is simply defined as a spontaneously generated virus mutant from which a critical portion of the virus genome has been deleted. At least one essential gene of the virus is deleted, either in its entirety, or sufficiently to make it non-functional. The resulting DI genome is then defective for replication in the absence of the product(s) of the deleted gene(s), and its replication requires the presence of the complete functional virus genome to provide the missing functions. In addition to being defective DI virus suppresses production of the helper virus in co-infected cells, and this process of interference can readily be observed in cultured cells. In some cases, DI virus has been observed to attenuate disease in virus-infected animals. In this article, we review the properties of DI virus, potential mechanisms of interference and progress in using DI virus (in particular that derived from influenza A virus) as a novel type of antiviral agent.
Similar articles
-
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.J Virol. 2021 Nov 23;95(24):e0117421. doi: 10.1128/JVI.01174-21. Epub 2021 Sep 22. J Virol. 2021. PMID: 34550771 Free PMC article.
-
Generation of a purely clonal defective interfering influenza virus.Microbiol Immunol. 2019 May;63(5):164-171. doi: 10.1111/1348-0421.12681. Epub 2019 May 17. Microbiol Immunol. 2019. PMID: 30997933
-
Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus.J Virol. 1978 Oct;28(1):375-86. doi: 10.1128/JVI.28.1.375-386.1978. J Virol. 1978. PMID: 702654 Free PMC article.
-
Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?J Virol. 2014 May;88(10):5217-27. doi: 10.1128/JVI.03193-13. Epub 2014 Feb 26. J Virol. 2014. PMID: 24574404 Free PMC article. Review.
-
Antivirotics based on defective interfering particles: emerging concepts and challenges.Front Cell Infect Microbiol. 2025 Feb 24;15:1436026. doi: 10.3389/fcimb.2025.1436026. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40066067 Free PMC article. Review.
Cited by
-
Effects of defective interfering RNA on symptom induction by, and replication of, a novel partitivirus from a phytopathogenic fungus, Rosellinia necatrix.J Virol. 2013 Feb;87(4):2330-41. doi: 10.1128/JVI.02835-12. Epub 2012 Dec 12. J Virol. 2013. PMID: 23236074 Free PMC article.
-
SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection.Emerg Microbes Infect. 2019;8(1):662-674. doi: 10.1080/22221751.2019.1611346. Emerg Microbes Infect. 2019. PMID: 31084471 Free PMC article.
-
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.J Virol. 2021 Nov 23;95(24):e0117421. doi: 10.1128/JVI.01174-21. Epub 2021 Sep 22. J Virol. 2021. PMID: 34550771 Free PMC article.
-
Comparative analysis of viral RNA signatures on different RIG-I-like receptors.Elife. 2016 Mar 24;5:e11275. doi: 10.7554/eLife.11275. Elife. 2016. PMID: 27011352 Free PMC article.
-
An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection.Sci Rep. 2017 Jul 5;7(1):4679. doi: 10.1038/s41598-017-04889-x. Sci Rep. 2017. PMID: 28680057 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical